|
18
|
99
|
4f75A |
Crystal structure of active hiv-1 protease in complex with the n terminal product of the substrate rh-in |
|
18
|
99
|
4f76A |
Crystal structure of the active hiv-1 protease in complex with the products of p1-p6 substrate |
|
19
|
99
|
4f73A |
Crystal structure of active hiv-1 protease in complex with the n terminal product of ca-p2 cleavage site |
|
18
|
99
|
4ejlA |
Apo hiv protease (pr) dimer in closed form with fragment 1f1-n in the outside/top of flap |
|
43
|
203
|
4eqjA |
Crystal structure of inactive single chain variant of hiv-1 protease in complex with the substrate rt-rh |
|
20
|
99
|
4dqhA |
Crystal structure of (r14c/e65c) hiv-1 protease in complex with drv |
|
44
|
203
|
4epjA |
Crystal structure of inactive single chain wild-type hiv-1 protease in complex with the substrate p2-nc |
|
19
|
99
|
4ejdA |
Hiv protease (pr) dimer in closed form with pepstatin in active site and fragment 1f1 in the outside/top of flap |
|
18
|
99
|
4dqfA |
Crystal structure of (g16a/l38a) hiv-1 protease in complex with drv |
|
43
|
203
|
4ep2A |
Crystal structure of inactive single chain wild-type hiv-1 protease in complex with the substrate rt-rh |
|
48
|
146
|
4e92A |
Crystal structure of the n-terminal domain of hiv-1 capsid in complex with inhibitor bm4 |
|
19
|
99
|
4dqcA |
Crystal structure of (g16c/l38c) hiv-1 protease in complex with drv |
|
42
|
203
|
4eq0A |
Crystal structure of inactive single chain variant of hiv-1 protease in complex with the substrate p2-nc |
|
17
|
99
|
4ej8A |
Apo hiv protease (pr) dimer in closed form with fragment 1f1 in the outside/top of flap |
|
48
|
152
|
4e1mA |
Crystal structure of hiv-1 integrase with a non-catayltic site inhibitor |
|
18
|
99
|
4dqbA |
Crystal structure of wild-type hiv-1 protease in complex with drv |
|
48
|
146
|
4e91A |
Crystal structure of the n-terminal domain of hiv-1 capsid in complex with inhibitor bd3 |
|
16
|
99
|
4dqgA |
Crystal structure of apo(g16c/l38c) hiv-1 protease |
|
18
|
99
|
4ejkA |
Hiv protease (pr) dimer in closed form with pepstatin in active site and fragment 1f1-n in the outside/top of flap |
|
46
|
152
|
4e1nA |
Crystal structure of hiv-1 integrase with a non-catayltic site inhibitor |
|
16
|
99
|
4e43A |
Hiv protease (pr) dimer with acetate in exo site and peptide in active site |
|
19
|
99
|
4dqeA |
Crystal structure of (g16c/l38c) hiv-1 protease in complex with drv |
|
49
|
155
|
4dmnA |
Hiv-1 integrase catalytical core domain |
|
19
|
99
|
4dfgA |
Crystal structure of wild-type hiv-1 protease with cyclopentyltetrahydro- furanyl urethanes as p2-ligand, grl-0249a |
|
15
|
99
|
4cpsA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
16
|
99
|
4cpxA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
24
|
84
|
4copA |
Hiv-1 capsid c-terminal domain mutant (y169s) |
|
47
|
143
|
4dgeC |
Trimcyp cyclophilin domain from macaca mulatta: h70c mutant, hiv-1 ca(o-loop) complex |
|
149
|
549
|
4dg1A |
Crystal structure of hiv-1 reverse transcriptase (rt) with polymorphism mutation k172a and k173a |
|
15
|
99
|
4cpqA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
48
|
145
|
4dgaC |
Trimcyp cyclophilin domain from macaca mulatta: hiv-1 ca(o-loop) complex |
|
15
|
99
|
4cp7A |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
115
|
427
|
4dg1B |
Crystal structure of hiv-1 reverse transcriptase (rt) with polymorphism mutation k172a and k173a |
|
16
|
99
|
4cprA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
16
|
99
|
4cpuA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
16
|
99
|
4coeA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
15
|
99
|
4cpwA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
28
|
75
|
4cocA |
Hiv-1 capsid c-terminal domain mutant (y169l) |
|
15
|
99
|
4cptA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
56
|
155
|
4ahuA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
3zptA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
60
|
154
|
4ahsA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
3zpsA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
58
|
153
|
4ahvA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
4a6bA |
Stereoselective synthesis, x-ray analysis, and biological evaluation of a new class of lactam based hiv-1 protease inhibitors |
|
16
|
99
|
3zpuA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
15
|
99
|
4a6cA |
Stereoselective synthesis, x-ray analysis, and biological evaluation of a new class of lactam based hiv-1 protease inhibitors |
|
55
|
154
|
4ahtA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
59
|
155
|
4ahrA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
59
|
156
|
4ah9A |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
